{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:54:53Z","timestamp":1794711293710,"version":"4.9.1"},"reference-count":138,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["GC-201711-2014197"],"award-info":[{"award-number":["GC-201711-2014197"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tem.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T07:17:34Z","timestamp":1712906254000},"page":"745-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of APOE4 on omega-3 brain metabolism across the lifespan"],"prefix":"10.1016","volume":"35","author":[{"given":"Brandon","family":"Ebright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon V.","family":"Duro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-649X","authenticated-orcid":false,"given":"Hussein N.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2024.03.003_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.852433","article-title":"DHA ameliorates cognitive ability, reduces amyloid deposition, and nerve fiber production in Alzheimer's disease","volume":"9","author":"Xiao","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.tem.2024.03.003_bb0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3233\/JAD-130131","article-title":"Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-beta42 by human microglia and decrease inflammatory markers","volume":"35","author":"Hjorth","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tem.2024.03.003_bb0015","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1074\/jbc.M110.182329","article-title":"Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms","volume":"286","author":"Grimm","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2024.03.003_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-4159.2009.06335.x","article-title":"Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function","volume":"111","author":"Cao","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tem.2024.03.003_bb0025","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1096\/fj.201901890RR","article-title":"Impairment of DHA synthesis alters the expression of neuronal plasticity markers and the brain inflammatory status in mice","volume":"34","author":"Talamonti","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2024.03.003_bb0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fphar.2019.01022","article-title":"N-3 polyunsaturated fatty acids and the resolution of neuroinflammation","volume":"10","author":"Joffre","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tem.2024.03.003_bb0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1051\/ocl.2011.0403","article-title":"Docosahexaenoic acid (DHA) in stroke, Alzheimer\u2019s disease, and blinding retinal degenerations: coping with neuroinflammation and sustaining cell survival","volume":"18","author":"Bazan","year":"2011","journal-title":"Ol\u00e9agineux Corps Gras Lipides"},{"key":"10.1016\/j.tem.2024.03.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101835","article-title":"New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: a scoping review","volume":"85","author":"Andriambelo","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tem.2024.03.003_bb0045","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jalz.2014.11.009","article-title":"MIND diet associated with reduced incidence of Alzheimer's disease","volume":"11","author":"Morris","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2024.03.003_bb0050","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/alz.12486","article-title":"Personalized nutrition for dementia prevention","volume":"18","author":"Samieri","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2024.03.003_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3945\/ajcn.114.103507","article-title":"Interaction between BMI and APOE genotype is associated with changes in the plasma long-chain-PUFA response to a fish-oil supplement in healthy participants","volume":"102","author":"Chouinard-Watkins","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tem.2024.03.003_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jamaneurol.2016.4899","article-title":"Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E epsilon4 carriers: a Review","volume":"74","author":"Yassine","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tem.2024.03.003_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mam.2017.12.004","article-title":"Brain docosahexaenoic acid uptake and metabolism","volume":"64","author":"Lacombe","year":"2018","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.tem.2024.03.003_bb0070","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1523\/JNEUROSCI.1583-16.2016","article-title":"Fatty acid-binding protein 5 at the blood-brain barrier regulates endogenous brain docosahexaenoic acid levels and cognitive function","volume":"36","author":"Pan","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2024.03.003_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100357","article-title":"Novel (13)C enrichment technique reveals early turnover of DHA in peripheral tissues","volume":"64","author":"Klievik","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.plefa.2013.09.004","article-title":"Kinetics of eicosapentaenoic acid in brain, heart and liver of conscious rats fed a high n-3 PUFA containing diet","volume":"89","author":"Igarashi","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.tem.2024.03.003_bb0085","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1194\/jlr.M600549-JLR200","article-title":"Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation","volume":"48","author":"Igarashi","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.plefa.2012.05.003","article-title":"Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo","volume":"88","author":"Rapoport","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.tem.2024.03.003_bb0095","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s12276-020-00503-9","article-title":"Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tem.2024.03.003_bb0100","doi-asserted-by":"crossref","first-page":"12525","DOI":"10.1073\/pnas.1807958115","article-title":"Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain","volume":"115","author":"Fernandez","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2024.03.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144351","article-title":"Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging","volume":"6","author":"Fernandez","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2024.03.003_bb0110","doi-asserted-by":"crossref","first-page":"12343","DOI":"10.1073\/pnas.1817557115","article-title":"ACSL6 is critical for maintaining brain DHA levels","volume":"115","author":"Chouinard-Watkins","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2024.03.003_bb0115","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1194\/jlr.M008334","article-title":"Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)beta (VIA)-deficient mice","volume":"51","author":"Basselin","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0120","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bbalip.2012.02.003","article-title":"Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)beta)-knockout mice","volume":"1821","author":"Cheon","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2024.03.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100113","article-title":"Omega-3 versus Omega-6 fatty acid availability is controlled by hydrophobic site geometries of phospholipase A(2)s","volume":"62","author":"Hayashi","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108395","article-title":"Molecular basis of unique specificity and regulation of group VIA calcium-independent phospholipase A(2) (PNPLA9) and its role in neurodegenerative diseases","volume":"245","author":"Hayashi","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tem.2024.03.003_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-017-0460-6","article-title":"Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A(2) in a spatial-specific manner","volume":"5","author":"Palavicini","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tem.2024.03.003_bb0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-022-00549-5","article-title":"Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4","volume":"17","author":"Wang","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2024.03.003_bb0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13195-022-01084-7","article-title":"Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia","volume":"14","author":"Ebright","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tem.2024.03.003_bb0150","article-title":"Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease","volume":"1866","author":"Oguro","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.tem.2024.03.003_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13195-021-00893-6","article-title":"Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's disease","volume":"13","author":"Borkowski","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tem.2024.03.003_bb0160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1194\/jlr.M800530-JLR200","article-title":"Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography","volume":"50","author":"Umhau","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-017-0250-1","article-title":"DHA brain uptake and APOE4 status: a PET study with [1-(11)C]-DHA","volume":"9","author":"Yassine","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tem.2024.03.003_bb0170","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1017\/S0007114513001268","article-title":"Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE epsilon4 allele","volume":"110","author":"Chouinard-Watkins","year":"2013","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.tem.2024.03.003_bb0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1017\/S0029665113003625","article-title":"Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline","volume":"73","author":"Hennebelle","year":"2014","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.tem.2024.03.003_bb0180","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1051\/ocl\/2018032","article-title":"Aging, cognitive decline, apolipoprotein E and docosahexaenoic acid metabolism","volume":"25","author":"Plourde","year":"2018","journal-title":"OCL"},{"key":"10.1016\/j.tem.2024.03.003_bb0185","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/jnc.12640","article-title":"Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2","volume":"129","author":"Vandal","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tem.2024.03.003_bb0190","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/md21070410","article-title":"A comparative study about the neuroprotective effects of DHA-enriched phosphatidylserine and EPA-enriched phosphatidylserine against oxidative damage in primary hippocampal neurons","volume":"21","author":"Wang","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.tem.2024.03.003_bb0195","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.bpj.2021.04.009","article-title":"EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol","volume":"120","author":"Jacobs","year":"2021","journal-title":"Biophys. J."},{"key":"10.1016\/j.tem.2024.03.003_bb0200","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.3390\/ijms241310717","article-title":"DHA\/EPA (Omega-3) and LA\/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases","volume":"24","author":"Kousparou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.03.003_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13190","article-title":"Decreased DHA-containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Abeta(42) , phosphorylated alpha-synuclein, and synaptopathology","volume":"33","author":"Chong","year":"2023","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tem.2024.03.003_bb0210","first-page":"104","article-title":"Roles and mechanisms of docosahexaenoic acid (DHA) in neurodevelopment, neuronal functions, learning and memory","volume":"40","author":"Evbuomwan","year":"2022","journal-title":"World News of Nat. Sci."},{"key":"10.1016\/j.tem.2024.03.003_bb0215","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/1570159X14666160614091311","article-title":"Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging","volume":"15","author":"Cutuli","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.tem.2024.03.003_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer's disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2024.03.003_bb0225","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.03.003_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2012.00081","article-title":"Functional metabolomics reveals novel active products in the DHA metabolome","volume":"3","author":"Shinohara","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2024.03.003_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","article-title":"Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases","volume":"19","author":"Spite","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2024.03.003_bb0240","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tem.2024.03.003_bb0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biochi.2020.08.015","article-title":"Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake","volume":"178","author":"Calder","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.tem.2024.03.003_bb0250","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/molecules27051677","article-title":"Resolvins, protectins, and maresins: DHA-derived specialized pro-resolving mediators, biosynthetic pathways, synthetic approaches, and their role in inflammation","volume":"27","author":"Ferreira","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tem.2024.03.003_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1098467","article-title":"Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development","volume":"14","author":"Alba","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tem.2024.03.003_bb0260","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2024.03.003_bb0265","doi-asserted-by":"crossref","first-page":"14426","DOI":"10.3390\/ijms232214426","article-title":"Inflammation and infection in pain and the role of GPR37","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.03.003_bb0270","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.3390\/ijms23094635","article-title":"Molecular and signaling mechanisms for docosahexaenoic acid-derived neurodevelopment and neuroprotection","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.03.003_bb0275","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1074\/jbc.R117.783076","article-title":"Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection","volume":"292","author":"Asatryan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2024.03.003_bb0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12035-011-8174-4","article-title":"Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models","volume":"43","author":"Stark","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2024.03.003_bb0285","article-title":"Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2024.03.003_bb0290","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","article-title":"Pro-resolving lipid mediators improve neuronal survival and increase Abeta42 phagocytosis","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2024.03.003_bb0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plefa.2017.01.012","article-title":"Dynamic interactions of n-3 and n-6 fatty acid nutrients","volume":"136","author":"Lands","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.tem.2024.03.003_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.plefa.2015.04.005","article-title":"Balancing proportions of competing omega-3 and omega-6 highly unsaturated fatty acids (HUFA) in tissue lipids","volume":"99","author":"Bibus","year":"2015","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.tem.2024.03.003_bb0305","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbi.2020.02.014","article-title":"Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: an exploratory study","volume":"87","author":"Cisbani","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tem.2024.03.003_bb0310","first-page":"13","article-title":"MAPT study: a multidomain approach for preventing Alzheimer's disease: design and baseline data","volume":"1","author":"Vellas","year":"2014","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.tem.2024.03.003_bb0315","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s12603-017-0957-5","article-title":"Cognitive changes with omega-3 polyunsaturated fatty acids in non-demented older adults with low omega-3 index","volume":"21","author":"Hooper","year":"2017","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.tem.2024.03.003_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101300","article-title":"Associations of Omega-3 fatty acids with brain morphology and volume in cognitively healthy older adults: a narrative review","volume":"67","author":"Macaron","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tem.2024.03.003_bb0325","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/S0029665120006989","article-title":"Omega-3 index in 2018\/19","volume":"79","author":"von Schacky","year":"2020","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.tem.2024.03.003_bb0330","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","article-title":"The Omega-3 Index: a new risk factor for death from coronary heart disease?","volume":"39","author":"Harris","year":"2004","journal-title":"Prev. Med."},{"key":"10.1016\/j.tem.2024.03.003_bb0335","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.0b013e318249f6a9","article-title":"Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging","volume":"78","author":"Tan","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2024.03.003_bb0340","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000448805","article-title":"Cognitive impairment is associated with a low omega-3 index in the elderly: results from the KORA-Age Study","volume":"42","author":"Lukaschek","year":"2016","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.tem.2024.03.003_bb0345","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ajcn\/nqac236","article-title":"Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses","volume":"116","author":"Rouch","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tem.2024.03.003_bb0350","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/ajcn\/nqac248","article-title":"The omega-3 index in Alzheimer's disease: ready for prime time?","volume":"116","author":"Yassine","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tem.2024.03.003_bb0355","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1021\/acs.molpharmaceut.5b00580","article-title":"Fatty acid-binding protein 5 facilitates the blood-brain barrier transport of docosahexaenoic acid","volume":"12","author":"Pan","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tem.2024.03.003_bb0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.03.003_bb0365","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1021\/acschemneuro.3c00681","article-title":"Synthesis and preclinical evaluation of 22-[(18)F]fluorodocosahexaenoic acid as a positron emission tomography probe for monitoring brain docosahexaenoic acid uptake kinetics","volume":"14","author":"Duro","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tem.2024.03.003_bb0370","doi-asserted-by":"crossref","first-page":"18760","DOI":"10.1073\/pnas.0708803104","article-title":"Selective changes of resting-state networks in individuals at risk for Alzheimer's disease","volume":"104","author":"Sorg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2024.03.003_bb0375","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1523\/JNEUROSCI.1400-19.2019","article-title":"ApoE4 alters ABCA1 membrane trafficking in astrocytes","volume":"39","author":"Rawat","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2024.03.003_bb0380","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1194\/jlr.M058164","article-title":"Neurite outgrowth stimulation by n-3 and n-6 PUFAs of phospholipids in apoE-containing lipoproteins secreted from glial cells","volume":"56","author":"Nakato","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281946","article-title":"Aging decreases docosahexaenoic acid transport across the blood\u2013brain barrier in C57BL\/6J mice","volume":"18","author":"Iwao","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2024.03.003_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102883","article-title":"Brain delivery of supplemental docosahexaenoic acid (DHA): a randomized placebo-controlled clinical trial","volume":"59","author":"Arellanes","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2024.03.003_bb0395","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/alz.12845","article-title":"Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias","volume":"19","author":"Yassine","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2024.03.003_bb0400","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.03.003_bb0405","doi-asserted-by":"crossref","first-page":"14307","DOI":"10.1038\/s41598-022-18325-2","article-title":"Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals","volume":"12","author":"Hong","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2024.03.003_bb0410","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jnnp-2021-328519","article-title":"APOE e4 dose associates with increased brain iron and beta-amyloid via blood\u2013brain barrier dysfunction","volume":"93","author":"Uchida","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tem.2024.03.003_bb0415","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","article-title":"APOEpsilon4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis","volume":"16","author":"Farmer","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2024.03.003_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104742","article-title":"APOE alters glucose flux through central carbon pathways in astrocytes","volume":"136","author":"Williams","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tem.2024.03.003_bb0425","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnagi.2020.00150","article-title":"APOE alleles and diet in brain aging and Alzheimer's disease","volume":"12","author":"Yassine","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tem.2024.03.003_bb0430","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2024.03.003_bb0435","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2024.03.003_bb0440","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/alz.13461","article-title":"Capillary dysfunction in healthy elderly APOE epsilon4 carriers with raised brain Abeta deposition","volume":"20","author":"Madsen","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2024.03.003_bb0445","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1096\/fj.201801412R","article-title":"Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease","volume":"33","author":"Patrick","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2024.03.003_bb0450","first-page":"810","article-title":"Baseline findings of PreventE4: a double-blind placebo controlled clinical trial testing high dose DHA in APOE4 carriers before the onset of dementia","volume":"10","author":"Yassine","year":"2023","journal-title":"J. Prev. Alzheimer's Dis."},{"key":"10.1016\/j.tem.2024.03.003_bb0455","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neurobiolaging.2018.05.017","article-title":"The effect of APOE genotype on Alzheimer's disease risk is influenced by sex and docosahexaenoic acid status","volume":"69","author":"Pontifex","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tem.2024.03.003_bb0460","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3945\/ajcn.112.053371","article-title":"DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial","volume":"97","author":"Stonehouse","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tem.2024.03.003_bb0465","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1096\/fj.201900423R","article-title":"Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice","volume":"33","author":"Martinsen","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2024.03.003_bb0470","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JAD-150102","article-title":"Plasma fatty acid profiles in relation to cognition and gender in Alzheimer's disease patients during oral omega-3 fatty acid supplementation: the OmegAD study","volume":"48","author":"Eriksdotter","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tem.2024.03.003_bb0475","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","article-title":"White matter lipids as a ketogenic fuel supply in aging female brain: implications for Alzheimer's disease","volume":"2","author":"Klosinski","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2024.03.003_bb0480","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tem.2024.03.003_bb0485","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2024.03.003_bb0490","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.03.003_bb0495","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","article-title":"Cholesterol and matrisome pathways dysregulated in astrocytes and microglia","volume":"185","author":"Tcw","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tem.2024.03.003_bb0500","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease","volume":"110","author":"Simons","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2024.03.003_bb0505","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000093478","article-title":"Fat intake at midlife and risk of dementia and Alzheimer\u2019s disease: a population-based study","volume":"22","author":"Laitinen","year":"2006","journal-title":"Dementia Geriatr. Cogn. Disord."},{"key":"10.1016\/j.tem.2024.03.003_bb0510","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s12603-021-1705-4","article-title":"A scoping review of dietary factors conferring risk or protection for cognitive decline in APOE \u03b54 carriers","volume":"25","author":"Fote","year":"2021","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.tem.2024.03.003_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100354","article-title":"Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness","volume":"64","author":"Bantugan","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2022.12.006","article-title":"Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease","volume":"123","author":"Madsen","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tem.2024.03.003_bb0525","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/alz.12357","article-title":"Water exchange rate across the blood-brain barrier is associated with CSF amyloid-beta 42 in healthy older adults","volume":"17","author":"Gold","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2024.03.003_bb0530","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/nutrit\/nuab078","article-title":"Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies","volume":"80","author":"Kosti","year":"2022","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.tem.2024.03.003_bb0535","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbi.2023.04.017","article-title":"Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: a network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy","volume":"111","author":"Tseng","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tem.2024.03.003_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2014.11.008","article-title":"Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis","volume":"48","author":"Wu","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tem.2024.03.003_bb0545","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jamda.2020.02.022","article-title":"Omega-3, omega-6, and polyunsaturated fat for cognition: systematic review and meta-analysis of randomized trials","volume":"21","author":"Brainard","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.tem.2024.03.003_bb0550","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.3390\/cancers12092477","article-title":"ATP production relies on fatty acid oxidation rather than glycolysis in pancreatic ductal adenocarcinoma","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2024.03.003_bb0555","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","article-title":"Altered glucose metabolism in Alzheimer's disease: role of mitochondrial dysfunction and oxidative stress","volume":"193","author":"Dewanjee","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tem.2024.03.003_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tem.2024.03.003_bb0565","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1089\/ars.2021.0177","article-title":"Altered metabolism in Alzheimer disease brain: role of oxidative stress","volume":"36","author":"Rummel","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tem.2024.03.003_bb0570","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00401-011-0836-9","article-title":"Peroxisomal alterations in Alzheimer's disease","volume":"122","author":"Kou","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2024.03.003_bb0575","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/623257","article-title":"Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB\u2013E)","volume":"2012","author":"Zarrouk","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tem.2024.03.003_bb0580","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOL.0000000000000801","article-title":"Lipids and brain inflammation in APOE4-associated dementia","volume":"33","author":"Duro","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.tem.2024.03.003_bb0585","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2967\/jnumed.107.049619","article-title":"Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET","volume":"49","author":"Esposito","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tem.2024.03.003_bb0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3164\/jcbn.22-61","article-title":"Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment","volume":"72","author":"Shichiri","year":"2023","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.tem.2024.03.003_bb0595","series-title":"Phospholipases in Physiology and Pathology","first-page":"307","article-title":"The genetics of phospholipase A2 induced redox signaling in neuroinflammation and neuronal diseases","author":"Maiti","year":"2023"},{"key":"10.1016\/j.tem.2024.03.003_bb0600","first-page":"1","article-title":"Mitochondrial production of perhydroxyl radical (HO2\u2022) as inducer of aging and age-related pathologies","volume":"1","author":"Panov","year":"2017","journal-title":"J. Biochem. Biophy."},{"key":"10.1016\/j.tem.2024.03.003_bb0605","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.2174\/0929867325666180117103919","article-title":"Targeting cytosolic phospholipase A2alpha for novel anti-inflammatory agents","volume":"25","author":"Soubhye","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tem.2024.03.003_bb0610","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/nyas.14907","article-title":"Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: application of single cell-type lipidomics","volume":"1518","author":"Asante","year":"2022","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2024.03.003_bb0615","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3390\/pharmaceutics14112438","article-title":"Increased expression and activity of brain cortical cPLA2 due to chronic lipopolysaccharide administration in mouse model of familial Alzheimer's disease","volume":"14","author":"Gynther","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tem.2024.03.003_bb0620","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.tem.2024.03.003_bb0625","series-title":"Phospholipases in Physiology and Pathology","first-page":"139","article-title":"PLA2: Implications in neurological disorders as a prospective therapeutic target","author":"Premrajan","year":"2023"},{"key":"10.1016\/j.tem.2024.03.003_bb0630","series-title":"Phospholipases in Physiology and Pathology","first-page":"79","article-title":"Cytosolic phospholipase A2 (cPLA2)-mediated oxidative and inflammatory responses in neurodegenerative diseases","author":"Hegde","year":"2023"},{"key":"10.1016\/j.tem.2024.03.003_bb0635","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/ijms24021353","article-title":"The phospholipase A2 superfamily: structure, isozymes, catalysis, physiologic and pathologic roles","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.03.003_bb0640","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1007\/s12035-018-1304-5","article-title":"Cytosolic phospholipase A(2) facilitates oligomeric amyloid-beta peptide association with microglia via regulation of membrane-cytoskeleton connectivity","volume":"56","author":"Teng","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2024.03.003_bb0645","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11064-015-1776-x","article-title":"The lipoxygenases: their regulation and implication in Alzheimer's disease","volume":"41","author":"Czapski","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0650","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ibra.12023","article-title":"The role of microglia in Alzheimer's disease and progress of treatment","volume":"8","author":"Guan","year":"2022","journal-title":"Ibrain"},{"key":"10.1016\/j.tem.2024.03.003_bb0655","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/metabo12111055","article-title":"In-vitro, in-vivo, molecular docking and ADMET studies of 2-substituted 3,7-dihydroxy-4H-chromen-4-one for oxidative stress, inflammation and Alzheimer's disease","volume":"12","author":"Mahnashi","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.tem.2024.03.003_bb0660","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-023-00344-2","article-title":"Alleviating the unwanted effects of oxidative stress on Abeta clearance: a review of related concepts and strategies for the development of computational modelling","volume":"12","author":"Somin","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tem.2024.03.003_bb0665","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00011-017-1022-x","article-title":"Effects of COX1-2\/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice","volume":"66","author":"Bitto","year":"2017","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.tem.2024.03.003_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070991","article-title":"Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles","volume":"8","author":"Chu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2024.03.003_bb0675","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s12035-018-1124-7","article-title":"Learning impairments, memory deficits, and neuropathology in aged Tau transgenic mice are dependent on leukotrienes biosynthesis: role of the cdk5 kinase pathway","volume":"56","author":"Giannopoulos","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2024.03.003_bb0680","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12695","article-title":"Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice","volume":"17","author":"Vagnozzi","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.tem.2024.03.003_bb0685","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11745-013-3791-5","article-title":"Regioisomers of phosphatidylcholine containing DHA and their potential to deliver DHA to the brain: role of phospholipase specificities","volume":"48","author":"Chen","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.tem.2024.03.003_bb0690","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3945\/ajcn.111.032094","article-title":"Association of PLA2G4A with myocardial infarction is modulated by dietary PUFAs","volume":"95","author":"Hartiala","year":"2012","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T19:46:10Z","timestamp":1723491970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276024000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":138,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1043276024000651"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2024.03.003","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of APOE4 on omega-3 brain metabolism across the lifespan","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}